Market Highlights
The Respiratory
Therapeutic Devices Market Size is anticipated to reach USD 12,231.6
Million by 2030 at 8.6% CAGR during the forecast period 2022-2030.
Respiratory therapeutic devices are used in the treatment,
management, and control of cardiopulmonary diseases such as chronic obstructive
pulmonary diseases (COPD), asthma, acute bronchitis, cystic
fibrosis, and others. Increasing prevalence of asthma drives the market
along with increasing per capita healthcare expenditure. According to the World
Health Organization in 2017, approximately 235 million people have asthma.
Moreover, it was estimated that in 2015, the diseases killed approximately 383
million patients around the globe. However, the market growth during the
forecast period is likely to hamper due to low per capita income in the
developing economies and lack of awareness.
Key Players
Global Respiratory
Therapeutic Devices Market Players are
Masimo. (U.S.),
BD. (U.S.),
Smiths Group Plc. (U.S.),
F. Hoffmann-La Roche Ltd (Europe),
Bayer AG (Europe),
Rotech Healthcare Inc. (U.S.),
Chart Industries (U.S.),
Acare Technology (Asia Pacific), and
others.
Segmentation
The global respiratory
therapeutic devices market is segmented on the basis of product,
technology, application, and end users.
On the basis of the product, the market is segmented
into nebulizers, capnography, humidifiers oxygen concentrators, and others. The
nebulizers segment is sub-segmented into soft mist inhaler, human-powered
nebulizer, and others. The capnography segment is sub-segmented into main-stream
capnography, side-stream capnography, and others.
On the basis of the technology, the market is
segmented into electrostatic filtration, HEPA filtration, hollow fiber
filtration, microsphere separation, and others.
On the basis of the application, the market is
segmented into asthma, chronic obstructive pulmonary disease (COPD), cystic
fibrosis, and others.
On the basis of the end users, the market is
segmented into hospitals & clinics, retail pharmacies, home care, and
others.
Regional Analysis
The Americas dominate the global respiratory therapeutic
devices market owing to a huge patient population having cardiopulmonary
diseases and well-developed healthcare sector. Moreover, the concentration of
the global players like Masimo., BD., Smiths Group plc., besides others along
with the increasing healthcare expenditure fuels the regional market growth
during the forecast period. In 2015, according to the Centers for Disease
Control and Prevention, in the U.S. the total healthcare expenditure accounted
for 17.8% of the total gross domestic product (GDP), which accounted for USD
3.2 trillion.
Europe is the second largest respiratory therapeutic devices
market owing to a well-developed healthcare infrastructure, government support
for research & development, and huge patient population. In 2017, according
to a study published in the Asthma Research and Practice Journal, the total
estimated cost per year for all the asthmatics per patient is about USD
1,900.
Asia Pacific is the fastest growing market due to the
presence of a huge patient population, continuously developing economies like
India and China, and the presence of huge opportunities in the market.
Moreover, favorable government policies and increasing healthcare expenditure
fuel the market within the region.
On the other hand, the Middle East & Africa holds the
least share of the global respiratory therapeutic devices market due to the
presence of poor economy, especially, within the African region. Majority of
the market of this region is held by the Middle East due to the huge healthcare
expenditure.
About US:
Market Research Future (MRFR) enable customers to unravel
the complexity of various industries through Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research
(CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media
Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013
